Sabinsa, the international ingredients company, has received notification that two additional patents have been granted.

The company’s Garcitrin^® product is now protected by Japanese patent number 4205943 for "Bioavailable composition of natural and synthetic HCA." The hydroxycitric acid (HCA) has been uniquely combined with garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica fruits, the result is GarCitrin^®. In GarCitrin^®, garcinol enhances the biological action of HCA and also contributes antioxidant activity to the formulation. A 12-week, double blind clinical with over 40 patients statistically proved GarCitrin^® is statistically more effective than HCA alone in:

• Reducing total body weight and body mass index
• Reducing body fat
• Increasing lean body mass
• Reducing levels of appetite perception